DRREDDY options
Dr. Reddy's Laboratories option chain and implied move
| Metric | Value | Read |
|---|---|---|
| Market-implied move | ±₹48.95 | ±3.98% to the Tuesday, 27 October 2026 expiry, from the at-the-money straddle |
| Implied range | ₹1,180.55 – ₹1,278.45 | What option prices imply, not a forecast of where the stock will trade |
| Max pain | ₹1,220 | The strike at which the largest value of written options would expire worthless |
| Heaviest put strike | ₹1,200 | 7,31,250 contracts — the largest put position on the chain |
| Heaviest call strike | ₹1,300 | 7,87,500 contracts — the largest call position on the chain |
| Put-call ratio | 0.70 | Total put open interest divided by total call open interest across the chain |
| Implied volatility (ATM) | 47.18% | At-the-money implied volatility for the front expiry |
- Market-implied move
- ±₹48.95
- Implied range
- ₹1,181 – ₹1,278
- Max pain
- ₹1,220
- Implied volatility
- 47.18%
±3.98% over 4 days, from the ₹1,230 straddle
What option prices imply, not a forecast of where the stock will trade
₹10 below the close
At the money, for the front expiry
Implied rangeMax painLast close
Heaviest put ₹1,200Heaviest call ₹1,300ATM ₹1,230 · PCR 0.70
At the close on Friday, 23 October 2026, Dr. Reddy's Laboratories options were pricing a move of ±₹48.95 by the Tuesday, 27 October 2026 expiry — a range of ₹1,180.55 to ₹1,278.45 against a closing price of ₹1,229.50. The figure is the at-the-money straddle at the ₹1,230 strike, which is what the options market itself is charging for the move to expiry. It describes the price of that expectation, not a forecast MarketCue makes.
Max pain sits at ₹1,220, ₹9.50 below the closing price — the strike at which the largest value of written options would expire worthless. The heaviest put position on the chain is at ₹1,200 with 7,31,250 contracts, and the heaviest call position at ₹1,300 with 7,87,500 contracts. Open interest describes where positions have been built; it is not a commitment by anyone to defend a price.
At-the-money implied volatility was 47.18% for the Tuesday, 27 October 2026 expiry. Realised volatility for Dr. Reddy's Laboratories is not yet available for comparison.
This page is a record of where Dr. Reddy's Laboratories's chain finished on Friday, 23 October 2026, not a live feed — the next reading follows tomorrow's close. Figures are derived from the NSE option chain via Upstox; max pain, the implied move, put-call ratio and the volatility comparison are MarketCue's own calculations from that data. MarketCue is not a registered investment adviser, research analyst or broker under SEBI regulations, and nothing here is a recommendation to buy or sell any security.
Read the full MarketCue scoring methodology
Source: NSE option chain via Upstox. .
Frequently asked questions
- What move are Dr. Reddy's Laboratories options pricing this expiry?
- ±₹48.95, or 3.98%, giving a range of ₹1,180.55 to ₹1,278.45 by Tuesday, 27 October 2026. The figure is derived from the at-the-money straddle at the ₹1,230 strike.
- What is Dr. Reddy's Laboratories's max pain?
- ₹1,220 at the last close, against a closing price of ₹1,229.50. Max pain is the strike at which the largest value of written options would expire worthless.
- Where is support and resistance in the Dr. Reddy's Laboratories option chain?
- The largest put position sits at ₹1,200 with 7,31,250 contracts, and the largest call position at ₹1,300 with 7,87,500 contracts. Traders commonly read heavy open interest at a strike as a level, though open interest describes positioning rather than any commitment to defend a price.
- What is the lot size for Dr. Reddy's Laboratories options?
- 625 shares per lot, with strikes in steps of ₹10. At the implied move of ±₹48.95, one lot corresponds to ±₹30,594 of notional movement.